Selenium Donor Inhibited Hepatitis B Virus Associated Hepatotoxicity via the Apoptosis and Ferroptosis Pathways

Figure 1

Serum selenium levels in HBV⁺-HCC patients, CHBs patients and the healthy controls. (a) Comparing the serum selenium level among HBV⁺-HCC patients, CHBs patients, and the healthy controls. (b) The ROC curve for serum selenium levels in relation to the HBV⁺-HCCs and CHBs. (c) Linear regression analysis between serum selenium levels and serum ALT, AST, TBIL, and ALB levels. (d) Overall survival curve and (e) disease-free survival curve of HBV⁺-HCC patients with different serum selenium level. HBV⁺-HCC: HBV positive HCC patients; CHBs: chronic hepatitis B virus infection patients; HCs: healthy controls; Se: selenium; ; ; .

(a)

(b)

(c)

(d)

(e)